Cannabinoids and mental health

被引：0
|
作者：
Soyka, M [1 ]
机构：
[1] Univ Munich, Psychiat Klin, D-80336 Munich, Germany
来源：
SCHMERZ | 2003年 / 17卷 / 04期
关键词：
cannabis; cannabinoids; psychiatric complications; mental health;
D O I：
10.1007/s00482-003-0226-x
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Cannabis and marihuana are psychoactive substances. Beside alcohol they belong to the most widely consumed drugs in most western countries. Psychiatric complications are frequent: substance use, dependence, possibly withdrawal, intoxications and cognitive dysfunction. There is substantial evidence for an increased risk for psychosis in chronic cannabis consumers. Recent data also indicate a high comorbidity with affective disorder. Chronic pain is only rarely mentioned as reasons for cannabis use, psychological or social reasons prevail. Psychiatric complications in cannabis consumers and its relevance for mental health are discussed.
引用
收藏
页码：268 / 273
页数：6
相关论文
共 50 条
  • [21] Mental health or mental healing?
    Katrien Libbrecht
    Society, 1997, 35 : 20 - 23
  • [22] Time to acknowledge the mixed effects of cannabis on health: a summary and critical review of the NASEM 2017 report on the health effects of cannabis and cannabinoids
    Cousijn, Janna
    Nunez, Adrian E.
    Filbey, Francesca M.
    ADDICTION, 2018, 113 (05) : 958 - 966
  • [23] Racism and mental health and the role of mental health professionals
    Schouler-Ocak, M.
    Bhugra, D.
    Kastrup, M. C.
    Dom, G.
    Heinz, A.
    Kuey, L.
    Gorwood, P.
    EUROPEAN PSYCHIATRY, 2021, 64 (01)
  • [24] Mental Health Messages in Prominent Mental Health Apps
    Parker, Lisa
    Bero, Lisa
    Gillies, Donna
    Raven, Melissa
    Mintzes, Barbara
    Jureidini, Jon
    Grundy, Quinn
    ANNALS OF FAMILY MEDICINE, 2018, 16 (04) : 338 - 342
  • [25] "No Health without Mental Health": Challenges and Opportunities in Global Mental Health
    Saxena, S.
    Skeen, S.
    AFRICAN JOURNAL OF PSYCHIATRY, 2012, 15 (06) : 397 - 400
  • [26] Neurological Complications of Cannabinoids
    Humayun, Mariyam
    Suarez, Jose I.
    Shah, Vishank A.
    SEMINARS IN NEUROLOGY, 2024, 44 (04) : 430 - 440
  • [27] Perspectives of cannabinoids in gastroenterology
    Storr, M
    Yüce, B
    Göke, B
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2006, 44 (02): : 185 - 191
  • [28] Review: Cannabinoids as Medicinals
    Khalsa, Jag H.
    Bunt, Gregory
    Blum, Kenneth
    Maggirwar, Sanjay B.
    Galanter, Marc
    Potenza, Marc N.
    CURRENT ADDICTION REPORTS, 2022, 9 (04) : 630 - 646
  • [29] Cannabinoids, interoception, and anxiety
    Andrade, Allyson K.
    Renda, Briana
    Murray, Jennifer E.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2019, 180 : 60 - 73
  • [30] Psychosis and synthetic cannabinoids
    Deng, Huiqiong
    Verrico, Christopher D.
    Kosten, Thomas R.
    Nielsen, David A.
    PSYCHIATRY RESEARCH, 2018, 268 : 400 - 412
12345